Related Experiment Video
Updated: Jun 8, 2026

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
Development and validation of a dissolution test for meloxicam and pridinol mesylate from combined tablet formulation
S E Vignaduzzo1, P M Castellano, T S Kaufman
1Institute of Chemistry, Rosario (IQUIR, CONICET-UNR), Suipach 513, 52002LRK, Rosario, Argentine.
Abstract:
The association of meloxicam and pridinol is indicated for treating muscular contractures and low back pain. A dissolution test for the meloxicam-pridinol combined tablet formulation was developed and validated, using a suitable HPLC method for simultaneously quantitating both dissolved drugs. The optimized conditions include the use of USP apparatus 2 at a paddle rotation rate of 75 rpm and 900 ml of 50 mM phosphate buffer (pH= 7.5) as dissolution medium, at 37.0±0.5°. The test, which demonstrated to be robust against small changes in bath temperature, paddle rotation speed and pH of the dissolution medium, was applied to two different brands of tablets; the corresponding dissolution profiles were constructed and both brands showed to dissolve at least 75% of the drugs at the 45 min time point.
Related Concept Videos
In Vitro Drug Dissolution: Compendial Testing Models I
Drug Dissolution: Requirements and Profile Comparison
In Vitro Drug Dissolution: Compendial Testing Models II
In Vitro Drug Dissolution: Alternative Methods
In Vitro Drug Release Testing: Overview, Development and Validation
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
